Tumor formation's two-step process: Mutated cells can persist for long periods without turning cancerous
Researchers at City of Hope have found that cell mutations are necessary but not always sufficient for tumors to form.
Case Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer
SAN ANTONIO, March 26, 2025--bioAffinity Technologies' CyPath Lung test uncovered a hidden second primary lung cancer in a patient who had been treated for lung cancer earlier.
EurekAlert!2d
City of Hope-led study demystifies tumor formation’s two-step process — a foundational understanding needed to prevent cancer
Researchers at City of Hope have found that cell mutations are necessary but not always sufficient for tumors to form.
UUHC Health Feed20d
Lung Cancers
The interdisciplinary team of lung cancer researcher Michelle Mendoza and biomedical engineer Jeffrey Weiss have received a multimillion dollar grant to study the origin of malignant tumors in the ...
Medscape3d
An Update on the Evaluation and Management of Small Pulmonary Nodules
The widespread utilization of chest CT scans has increased the importance of the proper evaluation of incidentally found lung nodules. The primary goal in the evaluation of these nodules is to ...
Medindia13d
Beyond Smoking: Poor Diet can Fuel Lung Cancer
Lung cancer isn’t just about smoking cigarettes! A poor diet can affect lung health and increase cancer risk. So, eat right ...
Physician's Weekly3d
Synergistic Strategies for Lung Cancer Immunotherapy: Combining Phytochemicals and Immune-Checkpoint Inhibitors.
Lung cancer remains one of the most widespread and deadliest malignant tumors globally, with a particularly high mortality rate among all cancers. Recently, immunotherapy, particularly immune ...